Citadel Advisors’s IRIDEX IRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-36,100
Closed -$31.9K 13419
2025
Q2
$31.9K Buy
+36,100
New +$36.8K ﹤0.01% 11963
2024
Q4
Sell
-500
Closed -$875 14926
2024
Q3
$875 Hold
500
﹤0.01% 13943
2024
Q2
$1.08K Sell
500
-4,300
-90% -$11.5K ﹤0.01% 13865
2024
Q1
$14.3K Sell
4,800
-1,600
-25% -$4.32K ﹤0.01% 13250
2023
Q4
$18K Buy
6,400
+6,300
+6,300% +$16.5K ﹤0.01% 12708
2023
Q3
$254 Buy
+100
New +$190 ﹤0.01% 14111
2023
Q1
Sell
-1,400
Closed -$2.81K 15084
2022
Q4
$2.81K Buy
+1,400
New +$3.11K ﹤0.01% 14279
2021
Q3
Sell
-10,400
Closed -$73K 14219
2021
Q2
$73K Buy
+10,400
New +$79K ﹤0.01% 13131

Other funds holding IRIX

Citadel Advisors's IRIX Position: Q1 2026 in Review

Citadel Advisors increased its IRIDEX (IRIX) stake by 77% in Q1 2026, buying an estimated $36.1K and bringing the position to 60,851 shares worth $61.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12320.

Citadel Advisors first reported a position in IRIX in Q2 2021 and has held it in 15 quarters since. The position peaked at $126K in Q3 2025. 25 funds tracked by Wall St. Rank hold IRIX as of Q1 2026.

  • Citadel Advisors held 60,851 shares of IRIDEX worth $61.5K as of Q1 2026.
  • Citadel Advisors bought 26,456 IRIDEX shares in Q1 2026, an estimated $36.1K.
  • IRIDEX made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12320 holding.
  • Citadel Advisors first reported a position in IRIDEX in Q2 2021 and has held it in 15 quarters since.
  • Citadel Advisors's IRIDEX position peaked at $126K in Q3 2025.
  • 25 funds tracked by Wall St. Rank held IRIDEX as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.